Zoek in de HOVON website
Let op!
Mogelijk ziet u niet alle beschikbare info op deze pagina, omdat u niet bent ingelogd, of omdat u niet de juiste privileges heeft.
Clinical picture: NHL (Non Hodgkin Lymphoma)
Trial: HOVON 137 NHL
News
1. Overview
2. Patient eligibility criteria
3. Registration (& randomization) of patients
4. Participating parties
5. Participating sites
6. Instruction videos
7. Download documentation / forms
News
HO137 news
07Jun2017: The trial will continue with Rixathon (rituximab biosimilar from Sandoz) instead of obinutuzumab. The new protocol is in development and participating sites are informed by email.
31Aug2016: Trial has been set on hold. Reason for this is that the GOYA study (obinutuzumab treatment for DLBCL) didn't reach its primary endpoint. Currently there are discussions with Roche about the continuation of the HO137. As soon as there is more information, participating sites will be informed.
1. Overview
Status
planned
Type of study
Prospective randomized Phase II study
Echelon level
Level D
Type of monitoring for this study
Site evaluation visits
Target number of patients
170